...
首页> 外文期刊>Frontiers in Cellular Neuroscience >miRNAs Plasma Profiles in Vascular Dementia: Biomolecular Data and Biomedical Implications
【24h】

miRNAs Plasma Profiles in Vascular Dementia: Biomolecular Data and Biomedical Implications

机译:血管性痴呆中的miRNA血浆概况:生物分子数据和生物医学意义。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Vascular dementia (VaD) is a pathogenetically heterogeneous neuropsychiatric syndrome, mainly characterized by cognitive impairment. Among dementias, it is second by incidence after Alzheimer’s dementia (AD). VaD biomolecular bases have been poorly characterized, but vascular-linked factors affecting the CNS and its functions are generally hypothesized to perform a major role, together with cardiovascular and immunological factors. miRNAs, which perform critically important biomolecular roles within cell networks, are also found in biological fluids as circulating miRNAs (cmiRNAs). We hypothesized that differentially expressed (DE) cmiRNAs in plasma from VaD patients could be applied to diagnose VaD through liquid biopsies; these profiles also could allow to start investigating VaD molecular bases. By exploiting TaqMan Low-Density Arrays and single TaqMan assays, miR-10b*, miR29a-3p, and miR-130b-3p were discovered and validated as significantly downregulated DE cmiRNAs in VaD patients compared to unaffected controls (NCs). These miRNAs also were found to be significantly downregulated in a matched cohort of AD patients, but miR-130b-3p levels were lower in AD than in VaD. A negative correlation was detected between miR-29a and miR-130b expression and cognitive impairment in VaD and AD, respectively. Receiver operating characteristic curves demonstrated that decreased plasma levels of miR-10b*, miR29a-3p, and miR-130b-3p allow to discriminate VaD and AD patients from NCs. Furthermore, the concurrent downregulation of both miR-10b* and miR-130b-3p in VaD showed an area under the curve (AUC) of 0.789 (p < 0.0001) with 75% of sensitivity and 72% of specificity, whereas an AUC of 0.789 (p < 0.0001) with 92% of sensitivity and 81% of specificity was found for both in AD. The miRNAs profiles reported in this paper pave the way to translational applications to molecular VaD diagnosis, but they also should allow to further investigate on its molecular bases.
机译:血管性痴呆(VaD)是一种病原性异质性神经精神病综合症,主要特征在于认知障碍。在痴呆症中,其发病率仅次于阿尔茨海默氏症(AD)。 VaD生物分子碱基的表征较差,但通常假设影响中枢神经系统及其功能的血管相关因素与心血管和免疫因素一起起主要作用。在细胞网络中起着至关重要的生物分子作用的miRNA,也以循环miRNA(cmiRNA)的形式存在于生物流体中。我们假设VaD患者血浆中的差异表达(DE)cmiRNAs可用于通过液体活检诊断VaD。这些概况也可以开始研究VaD分子碱基。通过利用TaqMan低密度阵列和单个TaqMan测定,与未受影响的对照(NC)相比,发现了miR-10b *,miR29a-3p和miR-130b-3p并被确认为VaD患者的DE cmiRNAs显着下调。在匹配的AD患者队列中也发现这些miRNA被显着下调,但AD中的miR-130b-3p水平低于VaD。在VaD和AD中分别检测到miR-29a和miR-130b表达与认知障碍之间存在负相关。接收器工作特征曲线表明,降低的miR-10b *,miR29a-3p和miR-130b-3p血浆水平可将VaD和AD患者与NC患者区分开。此外,miR-10b *和miR-130b-3p在VaD中的同时下调显示曲线下面积(AUC)为0.789(p <0.0001),灵敏度为75%,特异性为72%,而AUC为在AD中发现0.789(p <0.0001)的敏感性为92%,特异性为81%。本文报道的miRNA概况为分子VaD诊断中的翻译应用铺平了道路,但它们也应允许进一步研究其分子基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号